Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07561970

COmparison of Maintenance of Propofol And Sevoflurane Spectral Study

Lower EEG alpha band power is currently extensively studied as a potential biomarker of brain vulnerability. No previous study has evaluated whether there was a difference in EEG power spectrum ranges between propofol and sevoflurane, the two main anesthetic agents for maintenance of general anesthesia, in order to define a cut-off value for the prediction of a higher risk of postoperative delirium.

* Primary objective: comparison of EEG alpha power (dB) during maintenance of anesthesia with propofol and sevoflurane using data available in the NeuroSense® depth-of-anesthesia monitoring * Secondary objectives: comparison of other EEG frequency bands during maintenance of anesthesia with propofol and sevoflurane using data from the NeuroSense® depth-of-anesthesia monitoring

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cliniques universitaires Saint-Luc

Brussels, 1200, Belgium

Location status: Recruiting

Location contact

Aurélie Jacobs Sariyar, MD

SUB_INVESTIGATOR

Christine Watremez, MD PhD

SUB_INVESTIGATOR

Céline Khalifa, MD PhD

CONTACT

[email protected]

+3227641821

Céline Khalifa, MD PhD

PRINCIPAL_INVESTIGATOR

David Kahn, MD

SUB_INVESTIGATOR

Guillaume Lemaire, MD

SUB_INVESTIGATOR

Laetitia Miltoni, MD

CONTACT

+3227641821

Lina Puodzukaite, MD

SUB_INVESTIGATOR

Maximilien Cappe, MD

SUB_INVESTIGATOR

Mona Momeni, MD PhD

SUB_INVESTIGATOR

Robert Tircoveanu, MD

SUB_INVESTIGATOR

About this study

Since the development and commercialization of quantitative EEG monitors, which compute an index to assess the depth of sedation, the interest of anesthesiologists for neurophysiology has increased considerably. Indeed, frontal EEG represents an accessible, non-invasive technique to monitor the brain, the target-organ of our hypnotic drugs.

Anesthesia interferes with the physiological oscillations generated by the brain, and these disturbances impact the EEG. For instance, common hypnotic agents used for the maintenance of general anesthesia, intravenous propofol or inhaled sevoflurane, provide a typical pattern on the raw EEG related to their main mechanism of action: predominant simultaneous frontal slow/delta (0.1-4 Hz) and alpha (8-12 Hz) oscillations.

Intraoperative alpha oscillations are currently being extensively studied, as they might be a potential biomarker of brain vulnerability, which could help in predicting postoperative delirium, one of the most prevalent neurological complication after surgery. Recently, in a prospective observational cohort study including 220 patients, we showed that adult patients undergoing elective cardiac surgery under sevoflurane anesthesia who had lower intraoperative frontal EEG alpha band power were at higher risk of postoperative delirium. Lower intraoperative frontal EEG alpha band power was also correlated with poorer preoperative cognitive scores in our clinical series, which confirms previously published observations.

However, some practical questions still need to be addressed before this electroencephalographical marker can be integrated into a risk-prediction model for postoperative delirium. More specifically, we are not currently able to suggest a "universal" cut-off value for intraoperative frontal alpha-band power under general anesthesia that could be useful for a daily clinical practice. For example, an important issue is that the definition of the cut-off value will highly depend on the choice of anesthetic drugs. Although propofol and volatile anesthetics, such as sevoflurane, share similar neurophysiological characteristics, their respective EEG patterns and spectrograms are not identical (increased power in the thêta-band with volatile anesthetics). Otherwise, both propofol and sevoflurane EEG patters become completely different when they are used in combination with other anesthetic agents, such as benzodiazepines, ketamine or dexmedetomodine. These combinations are frequently used in multimodal anesthesia practice, and can deeply impact EEG frequency band power values. Consequently, at the moment, "low" alpha band power remains rather an observation on our patients' EEG spectrogram throughout surgery than a quantifiable value.

The main objective of this study is a first step towards to definition of a cut-off value for EEG frontal alpha band power to predict postoperative delirium. We aim to determine whether there is a significant difference in EEG power spectrum ranges between propofol and sevoflurane, the two main anesthetic maintenance agents. More precisely, it would require "simple", non-balanced, maintenance of general anesthesia using either propofol or sevoflurane, with the avoidance of any other hypnotic drugs. This type of maintenance is frequently used for minor interventions requiring general anesthesia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients undergoing elective electrophysiological interventions, such as atrial fibrillation ablation procedures, under general anesthesia

  • Capable to give informed consent
  • French-speaking patients

Exclusion criteria

  • Need for a premedication with benzodiazepine before anesthesia
  • Reduced left ventricular ejection fraction (< 50%) or underlying cardiac pathology requiring a more balanced anesthesia (administration of benzodiazepine and/or ketamine during anesthesia)
  • Preoperative MoCA score < 26/30 (for patients > ou = 55 years old)
  • Patients treated with anti-epileptic drugs
  • Patients treated with benzodiazepines (ex: for anxiolysis or sleep disorders)
  • Emergencies
  • Morbid obesity (BMI > 40kg/m2)
  • Background of severe postoperative nausea/vomit

Treatment and study plan

Maintenance of general anesthesia by Propofol

Other

Maintenance of general anesthesia for simple electrophysiological procedures

Maintenance of general anesthesia by Sevoflurane

Other

Maintenance of general anesthesia for simple electrophysiological procedures

Primary outcomes

  1. Alpha-band power

    Time frame: Intra-operative

    Power in decibels from the NeuroWave monitor under general anesthesia

Secondary outcomes

  1. Delta-band power

    Time frame: Intra-operative

    Power in decibels from the NeuroWave monitor

  2. Thêta-band power

    Time frame: Intra-operative

    Power in decibel from the NeuroWave monitor

  3. Bêta-band power

    Time frame: Intra-operative

    Power in decibel from the NeuroWave monitor

Sponsors and collaborators

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Other

Registry information

Official study title

Comparison of EEG Power Spectrum During Maintenance of Anesthesia With Propofol Versus Sevoflurane

Acronym: COMPASS

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
May 1, 2026
Registry last updated
May 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.